MX2011012460A - Proceso para la preparacion de olmesartan medoxomil. - Google Patents

Proceso para la preparacion de olmesartan medoxomil.

Info

Publication number
MX2011012460A
MX2011012460A MX2011012460A MX2011012460A MX2011012460A MX 2011012460 A MX2011012460 A MX 2011012460A MX 2011012460 A MX2011012460 A MX 2011012460A MX 2011012460 A MX2011012460 A MX 2011012460A MX 2011012460 A MX2011012460 A MX 2011012460A
Authority
MX
Mexico
Prior art keywords
preparation
olmesartan medoxomil
olm
eliminate
free
Prior art date
Application number
MX2011012460A
Other languages
English (en)
Inventor
Mohan Prasad
Ashwini Kumar Kapoor
Hiten Sharadchandra Mehta
Asok Nath
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of MX2011012460A publication Critical patent/MX2011012460A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención proporciona un proceso mejorado para la preparación de olmesartan medoxomil, que está libre de OLM-ácido y tiene menor cantidad de eliminación e impureza de ácido acético.
MX2011012460A 2009-05-20 2010-05-20 Proceso para la preparacion de olmesartan medoxomil. MX2011012460A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1037DE2009 2009-05-20
PCT/IB2010/052260 WO2010134052A1 (en) 2009-05-20 2010-05-20 Process for the preparation of olmesartan medoxomil

Publications (1)

Publication Number Publication Date
MX2011012460A true MX2011012460A (es) 2012-04-20

Family

ID=42306735

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011012460A MX2011012460A (es) 2009-05-20 2010-05-20 Proceso para la preparacion de olmesartan medoxomil.

Country Status (12)

Country Link
US (1) US20120184750A1 (es)
EP (1) EP2432777A1 (es)
JP (1) JP2012527446A (es)
KR (1) KR20120046115A (es)
CN (1) CN102459243A (es)
AP (1) AP2011005999A0 (es)
AU (1) AU2010250827A1 (es)
BR (1) BRPI1010969A2 (es)
CA (1) CA2762846A1 (es)
EA (1) EA201171413A1 (es)
MX (1) MX2011012460A (es)
WO (1) WO2010134052A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ305129B6 (cs) * 2010-11-24 2015-05-13 Zentiva, K.S. (5-Methyl-2-oxo-1,3-dioxol-4-ylmethyl)-4-(1-hydroxy-1-methyl-propyl)-2-propyl-1-[2´-(1H-tetrazol-5-yl)bifenyl-4-yl-methyl]imidazol-5-karboxylát jako nečistota olmesartan medoxomilu a způsob jeho přípravy
KR101418871B1 (ko) * 2012-08-28 2014-07-17 한국과학기술연구원 올메사탄 메독소밀의 정제방법
CN104447208B (zh) * 2014-11-28 2016-08-24 山东新华制药股份有限公司 从奥美沙坦酯生产废液中回收三苯基甲醇的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
EP0668272B1 (en) 1994-01-28 2000-07-12 Takeda Chemical Industries, Ltd. A process for the production of tetrazolyl compounds
PL1658281T3 (pl) 2003-08-27 2010-12-31 Zentiva Ks Sposób usuwania trifenylometanowej grupy zabezpieczającej
ITMI20032338A1 (it) 2003-11-28 2005-05-29 Dinamite Dipharma S P A In Forma A Bbreviata Diph Composti feniltetrazolici.
CA2573800A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Preparation of olmesartan medoxomil
EP1784398A1 (en) 2004-09-02 2007-05-16 Teva Pharmaceutical Industries Ltd Purification of olmesartan medoxomil
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
EP1812423A1 (en) 2004-11-11 2007-08-01 LEK Pharmaceuticals D.D. Process for the synthesis of tetrazoles
WO2006073518A1 (en) * 2004-12-30 2006-07-13 Teva Pharmaceutical Industries Ltd. Process for preparing olmesartan medoxomil at ph higher than 2.5
US7563814B2 (en) * 2005-01-03 2009-07-21 Teva Pharmaceutical Industries Ltd. Olmesartan medoxomil with reduced levels of impurities
CZ299902B6 (cs) 2005-10-27 2008-12-29 Zentiva, A. S Zpusob odstranování trifenylmethanové chránicí skupiny u prekurzoru antihypertenzních léciv
WO2007148344A2 (en) * 2006-06-19 2007-12-27 Matrix Laboratories Limited Process for the preparation of olmesartan medoxomil
JP5269798B2 (ja) * 2006-10-09 2013-08-21 シプラ・リミテッド トリチルオルメサルタンメドキソミルおよびオルメサルタンメドキソミルの製造方法

Also Published As

Publication number Publication date
AP2011005999A0 (en) 2011-12-31
CN102459243A (zh) 2012-05-16
BRPI1010969A2 (pt) 2019-01-15
KR20120046115A (ko) 2012-05-09
EA201171413A1 (ru) 2012-09-28
JP2012527446A (ja) 2012-11-08
AU2010250827A1 (en) 2012-01-19
EP2432777A1 (en) 2012-03-28
CA2762846A1 (en) 2010-11-25
US20120184750A1 (en) 2012-07-19
WO2010134052A1 (en) 2010-11-25

Similar Documents

Publication Publication Date Title
TN2011000673A1 (en) Bace inhibitors
AU2010230585A8 (en) Autotaxin inhibitors
IN2012DN03883A (es)
TW201129555A (en) Process for the manufacture of dabigatrane etexilate
MX341825B (es) Compuestos de heteroarilo y usos de los mismos.
GB0917002D0 (en) Improved shigella blebs
IN2012DN02081A (es)
JO2887B1 (en) Spiro-pyridine compounds as ORL-1 receptor antagonists
UA110197C2 (ru) Соединения, эффективные как ингибиторы для ксантиноксидазы, процесса получения таких соединений и фармацевтической композиции, содержащей терапевтически эффективное количество таких соединений.
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
MX2012004780A (es) Inhibidores de akt.
GEP20135933B (en) Compounds as bradykinin b1 antagonists
MX2011012993A (es) Bencimidazoles, benzotiazoles y benzoxazoles, sustituidos.
MX2012001413A (es) Compuestos azaheterociclicos novedosos.
WO2011014611A3 (en) Preparation of olmesartan medoxomil
WO2008075205A3 (en) Improved process for the preparation of voriconazole
MX339361B (es) Derivados de alternano.
WO2010079117A3 (en) Transplastomic plants free of the selectable marker
WO2012063269A3 (en) Process for preparing iloperidone
WO2011029536A3 (de) Verwendung von cyclischen ketoenolen gegen pflanzenpathogene bakterien
MY158090A (en) Novel solvate crystals
MX2011012460A (es) Proceso para la preparacion de olmesartan medoxomil.
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
EA201270390A1 (ru) 1,2,4-триазин, который может быть использован в качестве ускорителя вулканизации, и способ его получения
UA110626C2 (uk) Спосіб одержання пан-інгібіторів циклінзалежної кінази формули (i), а також проміжні продукти цього процесу одержання

Legal Events

Date Code Title Description
FA Abandonment or withdrawal